Newly Passed Chinese Patent Law Allows Government To Issue Compulsory Licenses On Patented Drugs
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The Third Amendment of China's new Patent Laws passed by the 6th Session of the 11th Standing Committee of the National People's Congress on Dec. 27, means that the government can issue compulsory licenses on patented drugs in China, according to the new amendment
You may also be interested in...
China To Implement New Regulations For Patent Law; Companies Should Set Up Inventor Reward Policy To Prepare For Changes
SHANGHAI - China's State Council recently approved new implementation regulations for the country's Patent law, which clarifies procedural issues in line with new changes to the patent law that took effect last year
China To Implement New Regulations For Patent Law; Companies Should Set Up Inventor Reward Policy To Prepare For Changes
SHANGHAI - China's State Council recently approved new implementation regulations for the country's Patent law, which clarifies procedural issues in line with new changes to the patent law that took effect last year
Intellectual Property Protection In China Improving In Incremental Stages - BioBusiness 2009 Conference
TAIPEI - China, generally thought to be a black hole for intellectual property, may be less dangerous for research-intensive pharmaceutical companies than is generally thought